Investigational Selective JAK1 Inhibitor Improves Measures of Disease Activity in RA.
- Published in:
- MD Conference Express, 2013, v. 13, n. 8, p. 18, doi. 10.1177/155989771308008
- By:
- Publication type:
- Article
Works matching IS 15598977 AND DT 2013 AND VI 13 AND IP 8
Results: 8
1
2
Predicting Response to Therapy: Works in Progress.
- Published in:
- MD Conference Express, 2013, v. 13, n. 8, p. 16, doi. 10.1177/155989771308007
- By:
- Publication type:
- Article
3
Efficacy Maintained When Transitioning Directly from TNF Inhibitor to Tofacitinib in RA.
- Published in:
- MD Conference Express, 2013, v. 13, n. 8, p. 8, doi. 10.1177/155989771308004
- By:
- Publication type:
- Article
4
CV Risk Persists in RA Patients despite Increased Medication Use for Both.
- Published in:
- MD Conference Express, 2013, v. 13, n. 8, p. 7, doi. 10.1177/155989771308003
- By:
- Publication type:
- Article
5
Abatacept and Adalimumab Equally Effective for Rheumatoid Arthritis.
- Published in:
- MD Conference Express, 2013, v. 13, n. 8, p. 6, doi. 10.1177/155989771308002
- By:
- Publication type:
- Article
6
Lower-Dose Etanercept Plus Methotrexate Shows Benefit for Early RA Patients in PRIZE Trial.
- Published in:
- MD Conference Express, 2013, v. 13, n. 8, p. 14, doi. 10.1177/155989771308006
- By:
- Publication type:
- Article
7
MOBILITY Part a Hones in on Effective Dosing for Sarilumab in RA.
- Published in:
- MD Conference Express, 2013, v. 13, n. 8, p. 9, doi. 10.1177/155989771308005
- By:
- Publication type:
- Article
8
EULAR Updates Recommendations for the Management of RA.
- Published in:
- MD Conference Express, 2013, v. 13, n. 8, p. 4, doi. 10.1177/155989771308001
- By:
- Publication type:
- Article